SERINE PROTEASE INHIBITORS Russian patent published in 2001 - IPC

Abstract RU 2172321 C2

FIELD: pharmaceutical chemistry. SUBSTANCE: invention provides serine protease inhibitors having piperidine side chain of general formula I: (I), wherein A is hydrogen atom, optionally substituted D, L-alpha-hydroxyacetyl, R1,R1-O-C(O)-,R1-SO2- and R2OOC-(CHR2)m-, in which R1 is selected from C1-C12-alkyl and C3-C8- cycloalkyl, indicated groups being optionally substituted by OH group, and C7-C15-arylalkyl; each group R2 independently denotes hydrogen atom or has the same denotations as indicated for R1; m=1,2 or 3; B denotes chemical bond, amino acid of formula -NH-CH[(CH2)pC(O)OH]-C(O)- with p=0,1,2, or 3, -N((1-12C)alkyl)-CH2-CO-, or D-1-Piq; or B represents D-amino acid having hydrophobic side chain; or A and B, taken together, represent group R3R4N-CHR5-C(O), in which R3 and R4 independently denote R1,R1-O-C(O)-,R1-C(O)-,R1-SO2- and R5 denotes hydrophobic or basic side chain; X represents L-amino acid with hydrophobic side chain; Y is CO-NH-C1-C6- alkylene-C6H5, -COOR6, in which R6 denotes hydrogen atom or C1-C6-alkyl, CONR7R8, in which R7 and R8, independent from each other, denote hydrogen atom or C1-C6- alkyl, or R7 and R8, taken together, represent C3-C6- alkylene; or Y denotes residue of heterocycle, selected from 2-thiazole, 2-benzothiazole, 20oxazole, or 2- benzoxazole; r = 0,1,2, or 3; or their pharmaceutically acceptable salts. Proposed compounds show anticoagulation activity and can be used for treating or preventing thrombin-caused diseases. Invention also provides pharmaceutical composition containing such inhibitor. EFFECT: increased assortment of anticoagulants. 15 cl, 2 tbl, 64 ex

Similar patents RU2172321C2

Title Year Author Number
SERINE PROTEASE INHIBITORS 1997
  • Anton Ehgbert Peter Adang
RU2178419C2
THROMBIN INHIBITORS 1996
  • Adang Anton Ehgbert Peter
  • Van Bukkel' Konstant Adrian Anton
  • Grotenkhjuis Peter Diderik Jan
  • Peters Jakobus Al'Bertus Marija
RU2178796C2
INHIBITORS OF SERINE PROTEASE 1997
  • Grotenkhejs Peter Diderik Jan
  • De Man Adrianus Petrus Antonius
  • Adang Anton Ehgbert Peter
RU2191193C2
DERIVATIVES OF IMIDAZO-[1,5-A]-PYRIDINE AS INHIBITORS OF SERINE PROTEASES AND PHARMACEUTICAL COMPOSITION 1996
  • Khenrikus Karl Jozef Ottenkhejm
  • Anton Ehgbert Peter Adang
  • Jakobus Al'Bertus Marija Peters
RU2175327C2
INHIBITORS OF SERINE PROTEASES 1998
  • Adang Anton Ehgbert Peter
RU2183642C2
PEPTIDE DERIVATIVES, THEIR STEREOISOMERS OR PHYSIOLOGICALLY ACCEPTABLE SALTS SHOWING ANTITHROMBOSIS, ANTICOAGULATING OR ANTI-INFLAMMATORY ACTIVITY, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF SUPPRESSION OF THROMBIN ACTIVITY, METHOD OF INHIBITION OF KININOGENASES ACTIVITY, USE OF COMPOUNDS AS PARENT SUBSTANCES FOR SYNTHESIS OF THROMBIN INHIBITOR 1994
  • Karl Tomas Antonsson
  • Rut Ehl'Vju Bjulund
  • Nil'S David Gustafsson
  • Nil'S Olov Ingemar Nil'Sson
RU2142469C1
STEROID COMPOUND, METHODS OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION 1998
  • Lozen Khubert Jan Jozef
RU2182153C2
FIVE-MEMBERED HETEROCYCLIC AMIDINES ELICITING PROPERTIES OF THROMBIN INHIBITORS, COMPOUNDS CONTAINING DERIVATIVES OF FIVE-MEMBERED HETEROCYCLIC AMIDINE AS COMPONENT OF INHIBITORS OF SERINE PROTEASES AND INTERMEDIATE COMPOUNDS 1997
  • Dorit Bauke
  • Udo Lange
  • Khel'Mut Mak
  • Verner Zajts
  • Tomas Tsirke
  • Khans Vol'Fgang Kheffken
  • Vil'Frid Khornberger
RU2175328C2
THROMBIN INHIBITORS AND INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS 1995
  • Bem Khans-Joakhim
  • Kozer Shtefan
  • Mak Khel'Mut
  • Pfajffer Tomas
  • Zajtts Verner
  • Kheffken Khans Vol'Fgang
  • Khornberger Vil'Frid
RU2172741C2
PEPTIDE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF THROMBIN INHIBITION IN MAMMAL 1995
  • Smit Dzheral'D Flojd
  • Uili Majkl Robert
  • Shakht Aaron Lejg
  • Shuman Robert Teodor
RU2148585C1

RU 2 172 321 C2

Authors

Anton Ehgbert Peter Adang

Jakobus Al'Bertus Marija Peters

Dates

2001-08-20Published

1997-02-26Filed